Isofol Medical: First patient included in Australia

Research Note

2020-01-27

10:46

Isofol reports that the first Australian patient has been included in the ongoing phase III trial AGENT. Considering the update, we believe that the company is on track to present interim results from the trial in Q3’20.

AN

Arvid Necander

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.